These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia. Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223 [TBL] [Abstract][Full Text] [Related]
25. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis. Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807 [TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis. Callahan SJ; Xia M; Murray S; Flaherty KR Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155 [TBL] [Abstract][Full Text] [Related]
27. Quantitative CT analysis of honeycombing area in idiopathic pulmonary fibrosis: Correlations with pulmonary function tests. Nakagawa H; Nagatani Y; Takahashi M; Ogawa E; Tho NV; Ryujin Y; Nagao T; Nakano Y Eur J Radiol; 2016 Jan; 85(1):125-130. PubMed ID: 26724656 [TBL] [Abstract][Full Text] [Related]
28. Clinical features and prognosis of microscopic polyangiitis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Zhao W; Dai H; Liu Y; Zhu M; Bao N; Ban C; Zhang S; Ren Y; Ye Q; Wang C Clin Respir J; 2019 Jul; 13(7):460-466. PubMed ID: 31013398 [TBL] [Abstract][Full Text] [Related]
30. Biomarkers and their potential functions in idiopathic pulmonary fibrosis. Ni S; Song M; Guo W; Guo T; Shen Q; Peng H Expert Rev Respir Med; 2020 Jun; 14(6):593-602. PubMed ID: 32187497 [No Abstract] [Full Text] [Related]
31. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis]. Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178 [TBL] [Abstract][Full Text] [Related]
32. Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. Miller ER; Putman RK; Diaz AA; Xu H; San José Estépar R; Araki T; Nishino M; Poli de Frías S; Hida T; Ross J; Coxson H; Dupuis J; O'Connor GT; Silverman EK; Rosas IO; Hatabu H; Washko G; Hunninghake GM Ann Am Thorac Soc; 2019 Apr; 16(4):447-454. PubMed ID: 30543456 [TBL] [Abstract][Full Text] [Related]
33. What parameters can be used to identify early idiopathic pulmonary fibrosis? Mori Y; Kondoh Y Respir Investig; 2021 Jan; 59(1):53-65. PubMed ID: 33277230 [TBL] [Abstract][Full Text] [Related]
34. Short-term Automated Quantification of Radiologic Changes in the Characterization of Idiopathic Pulmonary Fibrosis Versus Nonspecific Interstitial Pneumonia and Prediction of Long-term Survival. De Giacomi F; Raghunath S; Karwoski R; Bartholmai BJ; Moua T J Thorac Imaging; 2018 Mar; 33(2):124-131. PubMed ID: 29219887 [TBL] [Abstract][Full Text] [Related]
35. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. Kreuter M; Polke M; Walsh SLF; Krisam J; Collard HR; Chaudhuri N; Avdeev S; Behr J; Calligaro G; Corte T; Flaherty K; Funke-Chambour M; Kolb M; Kondoh Y; Maher TM; Molina Molina M; Morais A; Moor CC; Morisset J; Pereira C; Quadrelli S; Selman M; Tzouvelekis A; Valenzuela C; Vancheri C; Vicens-Zygmunt V; Wälscher J; Wuyts W; Wijsenbeek M; Cottin V; Bendstrup E Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32060068 [TBL] [Abstract][Full Text] [Related]
36. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910 [TBL] [Abstract][Full Text] [Related]
37. The comparison of high-resolution computed tomography findings in asbestosis and idiopathic pulmonary fibrosis. Akira M; Morinaga K Am J Ind Med; 2016 Apr; 59(4):301-6. PubMed ID: 26901505 [TBL] [Abstract][Full Text] [Related]
38. The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China. Lee VC; Yao J; Zhang W Global Health; 2021 Sep; 17(1):101. PubMed ID: 34488801 [TBL] [Abstract][Full Text] [Related]
40. Incidence and radiologic-pathological features of lung cancer in idiopathic pulmonary fibrosis. Liu Y; Zhu M; Geng J; Ban C; Zhang S; Chen W; Ren Y; He X; Chen W; Dai H Clin Respir J; 2018 Apr; 12(4):1700-1705. PubMed ID: 29094803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]